Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Menarini Stories

A new resource for dyslipidaemia management: Menarini Group launches UnlockLDLcontrol
Categories
menarini-com:blog/en/post-category/our-health

 

A silent but pressing challenge
Around 1 in 5 of people worldwide have high levels of low-density lipoprotein cholesterol (LDL-C).¹
This condition is a major contributor to cardiovascular disease, the leading cause of death worldwide.² The evidence is clear: reducing LDL-C lowers the risk of major cardiovascular events.2 The reality, however, tells a different story. Studies show that up to 80% of high-risk to very high riskpatients do not achieve their recommended LDL-C targets.2-5

The clinician at the centre
Healthcare professionals must navigate an increasingly complex landscape of evolving guidelines, emerging therapies and individualised risk assessment. While clinical dedication is fundamental, access to tailored tools and resources can further assist in helping patients reach their targets.

Introducing UnlockLDLcontrol
To address this need, the Menarini Group is proud to launch UnlockLDLcontrol, a new portal designed specifically for HCPs, built to consolidate essential resources and. The platform brings together the latest scientific guidance, practical tools and expert insights in one user-friendly space, helping clinicians save time and focus on what matters most: delivering better care.

A commitment that goes beyond the website
UnlockLDLcontrol is designed for healthcare professionals, but what it reflects is broader. It embodies Menarini Group’s ongoing commitment to bridging the gap between scientific evidence and everyday clinical practice. By translating scientific innovation into supportive resources, Menarini Group aims to assist clinicians in optimizing dyslipidaemia management and improving patient care.

Date of preparation: July 2026
 

Sources:

  1. Ballena-Caicedo J, et al. J Health Popul Nutr. 2025;44(1):308.
  2. Barrios V, et al. J Clin Med. 2023;12(9):3187.
  3. Ray KK, et al. Lancet Reg Health Eur. 2023;29:100624.
  4. Gitt AK, et al. Atherosclerosis. 2016;255:200-209.
  5. Cannon CP, et al. JAMA Cardiol. 2021;6(9):1060-1068.
  6. NHS. How to lower your cholesterol. Available at: https://www.nhs.uk/conditions/high-cholesterol/how-to-lower-your-cholesterol/  — Last accessed March 2026.